Pre-market Hot Trades in US Stocks
Presidio is up 10.96% in pre-market trading. Based on recent important news:
<ol>
<li>
On July 15, Presidio announced the purchase of 170,830 shares at $12.00 per share, demonstrating the company's confidence in its own stock, which drove the share price up.
</li>
<li>
On July 9, Presidio updated its model home activities, which may trigger market optimism regarding its business growth, further boosting the share price.
</li>
<li>
On June 13, CEO Jack Kendrick Heilbron increased his holdings in the company's common stock, enhancing market confidence and pushing the share price higher.
</li>
</ol>
Upexi is down 7.02% in pre-market trading. According to recent important news:
<ol>
<li>On August 12, Upexi announced that BitMEX co-founder Arthur Hayes joined the advisory board to drive strategic development and market exposure. However, the market reacted negatively to this news, leading to a 7.02% drop in the share price.</li>
</ol>
Top Gainers in Pre-market US Stocks
Expion360 is up 186.26% in pre-market trading. Based on recent important news:
<ol>
<li>
On August 13, Expion360 released its Q2 2025 financial report, showing a 134% year-over-year increase in GAAP revenue to $3 million, and a 38% improvement in net loss to $1.4 million, driving the share price significantly higher.
</li>
<li>
On August 13, the company's gross profit was $600,000, indicating an improvement in profitability, further boosting market confidence.
</li>
<li>
On August 13, the CEO stated during the earnings call that the company has ample inventory and is expected to continue growing in the future, enhancing investor optimism.
</li>
</ol>
Sonoma Pharmaceuticals is up 98.56% in pre-market trading. Based on recent important news:
<ol>
<li>
On August 5, Sonoma Pharmaceuticals projected a 19.4% increase in quarterly revenue, with analysts giving a &#34;strong buy&#34; rating and a target price 79.2% higher than the current price, driving the stock price up significantly.
</li>
<li>
Recently, the chemical pharmaceutical sector has performed strongly, increasing investor confidence in the pharmaceutical industry's prospects, boosting Sonoma Pharmaceuticals' stock price.
</li>
<li>
On August 6, Sonoma Pharmaceuticals is set to release its financial report, with market expectations optimistic, further stimulating the stock price increase.
</li>
</ol>
AERT is up 52.86% in pre-market trading. Based on recent key news:
<ol>
<li>
On July 17, Aeries Technology announced it has restored compliance with Nasdaq's minimum bid listing requirements, leading to a significant increase in the stock price.
</li>
<li>
On July 18, the company confirmed that it has fully resolved compliance issues without the need for hearings or appeals, further boosting market confidence.
</li>
<li>
On July 3, the company strengthened cost control and deepened cooperation with North American private equity-supported enterprises, looking forward to growth prospects in 2026
</li>
</ol>

SQFT

UPXI

Presidio Property Trust pre-market up 10.96%; Upexi pre-market down 7.02%; Expion360 pre-market up 186.26%; Sonoma Pharmaceuticals pre-market up 98.56%; Aeries Tech pre-market up 52.86%

Pre-market hot trades in the US stock market: Presidio Property Trust up 10.96% in pre-market; Upexi down 7.02% in pre-market